Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYK2 | P29597 | 19/20 | 0.42 |
| ▸ | JAK2 | O60674 | 4/20 | 0.41 |
| ▸ | JAK1 | P23458 | 4/20 | 0.41 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.40 |
| ▸ | STAT3 | P40763 | 2/20 | 0.39 |
| ▸ | JAK3 | P52333 | 2/20 | 0.39 |
| ▸ | STAT1 | P42224 | 1/20 | 0.39 |
| ▸ | BMPR2 | Q13873 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15690274 | 1.00 | TYK2 (0.42) | TYK2JAK2JAK1KCNH2STAT3 | |
| SCHEMBL29835067 | 0.91 | TYK2 (0.38) | TYK2JAK2JAK1KCNH2STAT3 | |
| SCHEMBL22635711 | 0.91 | TYK2 (0.40) | TYK2JAK2JAK1KCNH2STAT3 | |
| SCHEMBL26931418 | 0.84 | RAB9A (0.37) | — | |
| SCHEMBL10551128 | 0.83 | ALDH1A1 (0.46) | — | |
| SCHEMBL26934123 | 0.83 | RAB9A (0.38) | TYK2 | |
| SCHEMBL31398178 | 0.83 | ABCG2 (0.36) | TYK2JAK2 | |
| SCHEMBL26934121 | 0.83 | RAB9A (0.36) | TYK2 | |
| SCHEMBL26066345 | 0.82 | TDP1 (0.50) | — | |
| SCHEMBL22288355 | 0.82 | ALDH1A1 (0.38) | TYK2JAK2JAK1JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117756729-A | Preparation method of deuterium-celecoxib and intermediate thereof | 上海鼎雅药物化学科技有限公司 | 2024-03-26 | — | — | CN | claimed |
| CN-113490664-B | TYK2 inhibitors and uses thereof | 阿鲁米斯公司 | 2025-05-16 | — | — | CN | disclosed |
| WO-2024061118-A1 | MACROCYCLIC NITROGEN-CONTAINING CROWN ETHER COMPOUND AND USE THEREOF AS PROTEIN KINASE INHIBITOR | 科辉智药生物科技（无锡）有限公司 | 2024-03-28 | — | — | WO | disclosed |
| CN-117756729-A | Preparation method of deuterium-celecoxib and intermediate thereof | 上海鼎雅药物化学科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117756729-A | Preparation method of deuterium-celecoxib and intermediate thereof | 上海鼎雅药物化学科技有限公司 | 2024-03-26 | — | — | CN | disclosed |
| CN-117736198-A | Macrocyclic nitrogen crown ether compounds and their use as protein kinase inhibitors | 科辉智药生物科技(深圳)有限公司 | 2024-03-22 | — | — | CN | disclosed |
| CN-116490501-A | Tyrosine kinase 2 (TYK 2) degrading compounds and methods of use | 上海睿跃生物科技有限公司 | 2023-07-25 | — | — | CN | disclosed |
| WO-2022100710-A1 | TYROSINE KINASE 2 (TYK2) DEGRADATION COMPOUNDS AND METHODS OF USE | CULLGEN (SHANGHAI) , INC. (CN) | 2022-05-19 | — | — | WO | disclosed |